Point of Care/POC Diagnostics Market Size, Share, Analysis Report

Point of Care/POC Diagnostics Market Size By Mode of Purchase (OTC Products, Prescription-Based Products), By End User (Research Laboratories, Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, Other End Users), By Platform (Microfluidics, Molecular Diagnostics, Lateral Flow Assays, Dipsticks, Immunoassays), By Product (Cardiometabolic Monitoring Products, Glucose Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-Of-Abuse Testing Products), By Region (North America, Europe, Asia-Pacific, Rest of the World), Market Analysis Report, Forecast

The point-of-care diagnostics market is expected to be around US$ 67.30 billion by 2028 at a CAGR of 10.4%

Purchase User License

MARKET SNAPSHOT

Major Players

  • Accubiotech
  • Nova Biomedical
  • Instrumentation Laboratory
  • PTS Diagnostics
  • Sekisui Diagnostics
  • Study period:

    2023-2028

    Base Year:

    2022

    CAGR:

    10

    Fastest Growing Market:

    APAC

    Largest Market:

    North America

    REPORT DESCRIPTION

    Point of care tests have excessive potential for facilitating faster decision making and consequently more active patient care in the trauma care and emergency department of most hospitals and clinics. The main devices sought after in these sections are used for tests to amount blood gas and electrolyte concentration in the body. This particular segment offers important development opportunities for industry development. In line with this various market players are involved in developments and launch of various PoC diagnostic tests. Moreover, rapid testing through PoC diagnostic technologies is anticipated to decrease the duration of surgical procedures. For example, assessment of blood coagulation status can now be easily observed by bedside testers, reducing the requirement for blood stocking, and nullifying the threat from postoperative blood loss, which is common during complex procedures like heart bypass surgeries. The increase in geriatric population and their susceptibility towards various are augmenting growth of the Point of Care Diagnostics Market. This, joined with the increasing frequency of infectious diseases, is improving the market. The increase in disposable income of people worldwide has invigorated them to opt for better healthcare treatment and facilities. This is further predicted to fuel the demand for Point of Care Diagnostics Market in the coming years.

    The point-of-care diagnostics market is expected to be around US$ 67.30 billion by 2028 at a CAGR of 10.4%

    The global Point of Care/POC Diagnostics market is segregated on the basis of Mode of Purchase as OTC Products and Prescription-Based Products. Based on End User the global Point of Care/POC Diagnostics market is segmented in Research Laboratories, Professional Diagnostic Centers, Hospitals/Critical Care Centers, Home Care Settings, and Other End Users. Based on Platform the global Point of Care/POC Diagnostics market is segmented in Microfluidics, Molecular Diagnostics, Lateral Flow Assays, Dipsticks, and Immunoassays.

    Based on Product, the global Point of Care/POC Diagnostics market is segmented in Cardiometabolic Monitoring Products, Glucose Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, and Drugs-Of-Abuse Testing Products.

    The global Point of Care/POC Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Point of Care/POC Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.

    Competitive Rivalry

    Accubiotech, Instrumentation Laboratory, Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Abbott Laboratories, Becton, Dickinson, and Company, Chembio Diagnostics, Danaher Corporation, Johnson & Johnson, and others are among the major players in the global Point of Care/POC Diagnostics market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.

    The Point of Care/POC Diagnostics Market has been segmented as below:

    Point of Care/POC Diagnostics Market, By Mode of Purchase

    • OTC Products
    • Prescription-Based Products

    Point of Care/POC Diagnostics Market, By End User

    • Research Laboratories
    • Professional Diagnostic Centers
    • Hospitals/Critical Care Centers
    • Home Care Settings
    • Other End Users

    Point of Care/POC Diagnostics Market, By Platform

    • Microfluidics
    • Molecular Diagnostics
    • Lateral Flow Assays
    • Dipsticks
    • Immunoassays

    Point of Care/POC Diagnostics Market, By Product

    • Cardiometabolic Monitoring Products
    • Glucose Monitoring Products
    • Infectious Disease Testing Products
    • Coagulation Monitoring Products
    • Pregnancy & Fertility Testing Products
    • Tumor/Cancer Marker Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology Testing Products
    • Drugs-Of-Abuse Testing Products

    Point of Care/POC Diagnostics Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Point of Care/POC Diagnostics Market, By Company

    • Accubiotech
    • Instrumentation Laboratory
    • Nova Biomedical
    • PTS Diagnostics
    • Sekisui Diagnostics
    • Abbott Laboratories
    • Becton, Dickinson, and Company
    • Chembio Diagnostics
    • Danaher Corporation
    • Johnson & Johnson
    • Roche Diagnostics
    • Siemens Healthineers Group
    • EKF Diagnostics
    • Quidel
    • Trinity Biotech

    The report covers:

    • Global Point of Care/POC Diagnostics market sizes from 2021 to 2028, along with CAGR for 2023-2028
    • Market size comparison for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
    • Global Point of Care/POC Diagnostics market trends, covering comprehensive range of consumer trends & manufacturer trends
    • Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Point of Care/POC Diagnostics market
    • Major market opportunities and challenges in forecast timeframe to be focused
    • Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
    • Comprehensive company profiles of the key industry players

    Report Scope:

    The global Point of Care/POC Diagnostics market report scope includes detailed study covering underlying factors influencing the industry trends.

    The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.

    The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Point of Care/POC Diagnostics market share. Major industry players with significant revenue share include Accubiotech, Instrumentation Laboratory , Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Abbott Laboratories, Becton, Dickinson, and Company , Chembio Diagnostics, Danaher Corporation, Johnson & Johnson, and others.

    Reasons to Buy this Report:

    • Gain detailed insights on the Point of Care/POC Diagnostics industry trends
    • Find complete analysis on the market status
    • Identify the Point of Care/POC Diagnostics market opportunities and growth segments
    • Analyse competitive dynamics by evaluating business segments & product portfolios
    • Facilitate strategy planning and industry dynamics to enhance decision making

    Some of the recent developments in Point of Care/POC Diagnostics Market are as follows:

    Abbott Laboratories

    • 05-2020: Abbott Laboratories’ antibody test for the new coronavirus is extremely likely to correctly determine whether people have ever been diseased with the fast-spreading virus.
    • 03-2020: Abbott has declared that the U.S. Food and Drug Administration has dispensed Emergency Use Authorization  for the fastest available molecular point-of-care test for the detection of novel coronavirus, delivering positive results in as little as five minutes and negative results in 13 minutes.

    Customization

    Customized report as per the requirement can be offered with appropriate recommendations.

    Below are our New Reports :-

    Personal and Homecare Robotics Market

    mobile applications for melanoma detection market

    Endoscope Reprocessing Market

    Laboratory Glassware Washers market

    mHealth Market

    1.    Introduction

    1.1.    Key Take Aways
    1.2.    Report Description
    1.3.    Markets Covered
    1.4.    Stakeholders

    2.    Research Methodology

    2.1.    Research Scope
    2.2.    Research Methodology
    2.2.1.    Market Research Process
    2.2.2.    Research Methodology
    2.2.2.1.    Secondary Research
    2.2.2.2.    Primary Research
    2.2.2.3.    Models for Estimation
    2.3.    Market Size Estimation
    2.3.1.    Bottom-Up Approach
    2.3.2.    Top-Down Approach

    3.    Executive Summary

    4.    Market Overview

    4.1.    Introduction
    4.2.    Drivers
    4.3.    Restraints

    5.    Point of Care Diagnostics Market, By Product

    5.1.    Key Points
    5.2.    Tumor/Cancer Marker Testing Products
    5.3.    Urinalysis Testing Products
    5.4.    Cholesterol Testing Products
    5.5.    Hematology Testing Products
    5.6.    Drugs-of-abuse Testing Products
    5.7.    Fecal Occult Testing Products
    5.8.    Other POC Products
    5.9.    Pregnancy & Fertility Testing Products
    5.10.    Coagulation Monitoring Products
    5.11.    Infectious Disease Testing Products
    5.12.    Cardiometabolic Monitoring Products
    5.13.    Glucose Monitoring Products

    6.    Point of Care Diagnostics Market, By Mode of Purchase

    6.1.    Key Points
    6.2.    OTC Products
    6.3.    Prescription-based Products

    7.    Point of Care Diagnostics Market, By End-User

    7.1.    Key Points
    7.2.    Home Care Settings
    7.3.    Hospitals/Critical Care Centers
    7.4.    Clinical Laboratories and Outpatient Healthcare & Ambulatory Care Settings
    7.5.    Other End Users

    8.    Point of Care Diagnostics Market, By Platform

    8.1.    Key Points
    8.2.    Microfluidics
    8.3.    Molecular Diagnostics
    8.4.    Immunoassays
    8.5.    Lateral Flow Assays
    8.6.    Dipsticks

    9.    Point of Care Diagnostics Market, By Region

    9.1.     Key Points
    9.2.    North America
    9.2.1.    U.S
    9.2.2.    Canada
    9.2.3.    Mexico
    9.3.    Europe
    9.3.1.    Spain
    9.3.2.    Russia
    9.3.3.    Turkey
    9.3.4.    Belgium
    9.3.5.    Netherlands
    9.3.6.    Germany
    9.3.7.    France
    9.3.8.    Italy
    9.3.9.    Rest of Europe
    9.4.    Asia Pacific
    9.4.1.    China
    9.4.2.    Japan
    9.4.3.    India
    9.4.4.    Australia
    9.4.5.    Rest of Asia Pacific
    9.5.    Rest of World
    9.6.    Competitive Landscape
    9.7.    Introduction
    9.8.    Recent Developments
    9.8.1.    Mergers & Acquisitions
    9.8.2.    New Product Developments
    9.8.3.    Portfolio/Production Capacity Expansions
    9.8.4.    Joint Ventures, Collaborations, Partnerships & Agreements
    9.8.5.    Others

    10.     Company Profile

    10.1.    Sekisui Diagnostics
    10.1.1.    Company Overview
    10.1.2.    Product/Service Landscape
    10.1.3.    Financial Overview
    10.1.4.    Recent Developments
    10.2.    PTS Diagnostics 
    10.2.1.    Company Overview
    10.2.2.    Product/Service Landscape
    10.2.3.    Financial Overview
    10.2.4.    Recent Developments
    10.3.    Nova Biomedical
    10.3.1.    Company Overview
    10.3.2.    Product/Service Landscape
    10.3.3.    Financial Overview
    10.3.4.    Recent Developments
    10.4.    Instrumentation Laboratory
    10.4.1.    Company Overview
    10.4.2.    Product/Service Landscape
    10.4.3.    Financial Overview
    10.4.4.    Recent Developments
    10.5.    Accubiotech
    10.5.1.    Company Overview
    10.5.2.    Product/Service Landscape
    10.5.3.    Financial Overview
    10.5.4.    Recent Developments
    10.6.    Trinity Biotech
    10.6.1.    Company Overview
    10.6.2.    Product/Service Landscape
    10.6.3.    Financial Overview
    10.6.4.    Recent Developments
    10.7.    Quidel 
    10.7.1.    Company Overview
    10.7.2.    Product/Service Landscape
    10.7.3.    Financial Overview
    10.7.4.    Recent Developments
    10.8.    EKF Diagnostics
    10.8.1.    Company Overview
    10.8.2.    Product/Service Landscape
    10.8.3.    Financial Overview
    10.8.4.    Recent Developments
    10.9.    Siemens Healthineers Group
    10.9.1.    Company Overview
    10.9.2.    Product/Service Landscape
    10.9.3.    Financial Overview
    10.9.4.    Recent Developments
    10.10.    Roche Diagnostics
    10.10.1.    Company Overview
    10.10.2.    Product/Service Landscape
    10.10.3.    Financial Overview
    10.10.4.    Recent Developments
    10.11.    Johnson & Johnson
    10.11.1.    Company Overview
    10.11.2.    Product/Service Landscape
    10.11.3.    Financial Overview
    10.11.4.    Recent Developments
    10.12.    Danaher Corporation
    10.12.1.    Company Overview
    10.12.2.    Product/Service Landscape
    10.12.3.    Financial Overview
    10.12.4.    Recent Developments
    10.13.    Chembio Diagnostics
    10.13.1.    Company Overview
    10.13.2.    Product/Service Landscape
    10.13.3.    Financial Overview
    10.13.4.    Recent Developments
    10.14.    Becton, Dickinson, and Company
    10.14.1.    Company Overview
    10.14.2.    Product/Service Landscape
    10.14.3.    Financial Overview
    10.14.4.    Recent Developments
    10.15.    Abbott Laboratories
    10.15.1.    Company Overview
    10.15.2.    Product/Service Landscape
    10.15.3.    Financial Overview
    10.15.4.    Recent Developments

    The Point of Care/POC Diagnostics Market has been segmented as below:

    Point of Care/POC Diagnostics Market, By Mode of Purchase

    • OTC Products
    • Prescription-Based Products

    Point of Care/POC Diagnostics Market, By End User

    • Research Laboratories
    • Professional Diagnostic Centers
    • Hospitals/Critical Care Centers
    • Home Care Settings
    • Other End Users

    Point of Care/POC Diagnostics Market, By Platform

    • Microfluidics
    • Molecular Diagnostics
    • Lateral Flow Assays
    • Dipsticks
    • Immunoassays

    Point of Care/POC Diagnostics Market, By Product

    • Cardiometabolic Monitoring Products
    • Glucose Monitoring Products
    • Infectious Disease Testing Products
    • Coagulation Monitoring Products
    • Pregnancy & Fertility Testing Products
    • Tumor/Cancer Marker Testing Products
    • Urinalysis Testing Products
    • Cholesterol Testing Products
    • Hematology Testing Products
    • Drugs-Of-Abuse Testing Products

    Point of Care/POC Diagnostics Market, By Region

    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World

    Point of Care/POC Diagnostics Market, By Company

    • Accubiotech
    • Instrumentation Laboratory
    • Nova Biomedical
    • PTS Diagnostics
    • Sekisui Diagnostics
    • Abbott Laboratories
    • Becton, Dickinson, and Company
    • Chembio Diagnostics
    • Danaher Corporation
    • Johnson & Johnson
    • Roche Diagnostics
    • Siemens Healthineers Group
    • EKF Diagnostics
    • Quidel
    • Trinity Biotech

    Got a question? We've got answers. If you have some other questions, see our support center.

    The market is expected to grow at a CAGR of 10.4% during the study period (2023-2028)
    The point-of-care diagnostics market is expected to be around US$ 67.30 billion by 2028
    The segment included in the Point of Care/POC Diagnostics market is Mode of Purchase, End User, Platform, Product, Company and region.
    Some key players operating in the Point of Care/POC Diagnostics market include Accubiotech, Instrumentation Laboratory, Nova Biomedical, PTS Diagnostics, Sekisui Diagnostics, Abbott Laboratories, Becton, Dickinson, and Company
    We can offer several formats of the market research reports including, • PDF • PPT • Spreadsheet/ Workbook

    Related Reports